Dry Powder Inhaler + inhaled mosliciguat for lung diseases, interstitial

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Dec 2025: Trial started, NCT07333183
  2. 12 Jan 2026: Trial registered, NCT07333183

The trials

NCT07333183: A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

State
Under way
Phase
Phase 2
People
20 planned
Started
23 Dec 2025
Primary completion
Dec 2026
Arms
Active Comparator: inhaled mosliciguat, Extension: inhaled mosliciguat
Results
None posted
  1. 23 Dec 2025: Trial started
  2. 12 Jan 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.